These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38040880)

  • 1. Lactate dehydrogenase and hemolysis index to predict vaso-occlusive crisis in sickle cell disease.
    Feugray G; Dumesnil C; Grall M; Benhamou Y; Girot H; Fettig J; Brunel V; Billoir P
    Sci Rep; 2023 Dec; 13(1):21198. PubMed ID: 38040880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients.
    Stankovic Stojanovic K; Steichen O; Lefevre G; Bachmeyer C; Avellino V; Grateau G; Girot R; Lionnet F
    Clin Biochem; 2012 Dec; 45(18):1578-82. PubMed ID: 22892192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.
    Alp G; Oztas Y; Yalcinkaya A; Ozel S; Yildirim N; Unal S
    Lipids; 2024 May; 59(3):75-82. PubMed ID: 38332401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease.
    Feugray G; Kasonga F; Grall M; Dumesnil C; Benhamou Y; Brunel V; Le Cam Duchez V; Lahary A; Billoir P
    Front Cardiovasc Med; 2022; 9():883812. PubMed ID: 36277754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India.
    Meher S; Patel S; Das K; Dehury S; Jit BP; Maske MM; Das P; Dash BP; Mohanty PK
    Ann Hematol; 2019 Oct; 98(10):2257-2265. PubMed ID: 31440871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome.
    Yildirim N; Unal S; Yalcinkaya A; Karahan F; Oztas Y
    Ann Hematol; 2022 Jan; 101(1):35-41. PubMed ID: 34564750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HO-1
    Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K
    Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
    Al Najjar S; Adam S; Ahmed N; Qari M
    Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Meher S; Mohanty PK; Patel S; Das K; Sahoo S; Dehury S; Mohapatra MK; Jit BP; Das P; Dash BP
    Hemoglobin; 2021 Nov; 45(6):358-364. PubMed ID: 33393394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
    Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
    J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
    Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
    J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
    Elshazly SA; Heiba NM; Abdelmageed WM
    Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
    Antwi-Boasiako C; Campbell AD
    Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease.
    Feugray G; Kasonga F; Grall M; Benhamou Y; Bobée-Schneider V; Buchonnet G; Daliphard S; Le Cam Duchez V; Lahary A; Billoir P
    Front Med (Lausanne); 2022; 9():858911. PubMed ID: 35492334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.
    Koh C; Turner T; Zhao X; Minniti CP; Feld JJ; Simpson J; Demino M; Conrey AK; Jackson MJ; Seamon C; Kleiner DE; Kato GJ; Heller T
    Am J Hematol; 2013 Nov; 88(11):E250-4. PubMed ID: 23828202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
    Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease.
    Cieri-Hutcherson NE; Hutcherson TC; Conway-Habes EE; Burns BN; White NA
    Pharmacotherapy; 2019 Nov; 39(11):1095-1104. PubMed ID: 31505045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.